Matches in SemOpenAlex for { <https://semopenalex.org/work/W4236098321> ?p ?o ?g. }
Showing items 1 to 62 of
62
with 100 items per page.
- W4236098321 endingPage "ec140" @default.
- W4236098321 startingPage "ec140" @default.
- W4236098321 abstract "Rupture of atherosclerotic plaques in blood vessels disrupts endothelium and exposes collagen, a potent trigger for recruiting and aggregating platelets during thrombosis. A key signaling pathway in this process is the thrombin-mediated cleavage of protease-activated receptor 1 (PAR1) on platelets. Trivedi et al. found that matrix metalloprotease 1 (MMP-1) on platelets also cleaves PAR1, but at a site distinct from that cleaved by thrombin. Treatment of platelets with a peptide corresponding to the MMP-1 cleavage product of PAR1 activated the guanosine triphosphatase RhoA (which was blocked by the PAR1 antagonist RWJ-56110) and the p38 mitogen-activated protein kinase (MAPK). The inactive form of MMP-1 (pro-MMP-1) associated with the collagen receptor αIIbβ3 integrin. Like the MMP-1–generated PAR1 cleavage fragment, collagen treatment of platelets activated RhoA and p38 MAPK, which was blocked by PAR1 antagonists or the MMP-1 inhibitor FN-439. An in vitro assay in which anticoagulated blood was flowed over collagen-coated surfaces at rates that produced high shear stress conditions showed that pretreatment of platelets with either MMP-1 or PAR1 inhibitors did not affect their adhesion but decreased the initiation and propagation of thrombi, an effect not observed with thrombin inhibitors. Platelet activation in guinea pigs in response to direct injection of collagen was reduced by inhibition of MMP-1 or PAR1. FeCl3 injection causes injury in the carotid artery similar to that caused by rupture of atherosclerotic plaques, and eventually the artery becomes occluded because of thrombosis at the injury site. However, administration of either MMP-1 or PAR1 antagonists increased the time required for complete arterial occlusion. Furthermore, platelets in clots contained higher MMP-1 activity compared with platelets from uninjured animals or animals treated with FN-439 before FeCl3 injection. The authors propose that MMP-1 activation of PAR1 is required for the early stages of thrombosis and may be a potential therapeutic target for preventing arterial thrombosis." @default.
- W4236098321 created "2022-05-12" @default.
- W4236098321 creator A5084302718 @default.
- W4236098321 date "2009-04-21" @default.
- W4236098321 modified "2023-10-17" @default.
- W4236098321 title "Clotting Factor" @default.
- W4236098321 doi "https://doi.org/10.1126/scisignal.267ec140" @default.
- W4236098321 hasPublicationYear "2009" @default.
- W4236098321 type Work @default.
- W4236098321 citedByCount "0" @default.
- W4236098321 crossrefType "journal-article" @default.
- W4236098321 hasAuthorship W4236098321A5084302718 @default.
- W4236098321 hasConcept C126322002 @default.
- W4236098321 hasConcept C149577978 @default.
- W4236098321 hasConcept C170493617 @default.
- W4236098321 hasConcept C185592680 @default.
- W4236098321 hasConcept C195687474 @default.
- W4236098321 hasConcept C2777093181 @default.
- W4236098321 hasConcept C2777292125 @default.
- W4236098321 hasConcept C2778863912 @default.
- W4236098321 hasConcept C3018697912 @default.
- W4236098321 hasConcept C55493867 @default.
- W4236098321 hasConcept C62478195 @default.
- W4236098321 hasConcept C71924100 @default.
- W4236098321 hasConcept C86803240 @default.
- W4236098321 hasConcept C89560881 @default.
- W4236098321 hasConcept C95444343 @default.
- W4236098321 hasConceptScore W4236098321C126322002 @default.
- W4236098321 hasConceptScore W4236098321C149577978 @default.
- W4236098321 hasConceptScore W4236098321C170493617 @default.
- W4236098321 hasConceptScore W4236098321C185592680 @default.
- W4236098321 hasConceptScore W4236098321C195687474 @default.
- W4236098321 hasConceptScore W4236098321C2777093181 @default.
- W4236098321 hasConceptScore W4236098321C2777292125 @default.
- W4236098321 hasConceptScore W4236098321C2778863912 @default.
- W4236098321 hasConceptScore W4236098321C3018697912 @default.
- W4236098321 hasConceptScore W4236098321C55493867 @default.
- W4236098321 hasConceptScore W4236098321C62478195 @default.
- W4236098321 hasConceptScore W4236098321C71924100 @default.
- W4236098321 hasConceptScore W4236098321C86803240 @default.
- W4236098321 hasConceptScore W4236098321C89560881 @default.
- W4236098321 hasConceptScore W4236098321C95444343 @default.
- W4236098321 hasIssue "67" @default.
- W4236098321 hasLocation W42360983211 @default.
- W4236098321 hasOpenAccess W4236098321 @default.
- W4236098321 hasPrimaryLocation W42360983211 @default.
- W4236098321 hasRelatedWork W149121501 @default.
- W4236098321 hasRelatedWork W1973453444 @default.
- W4236098321 hasRelatedWork W2023552723 @default.
- W4236098321 hasRelatedWork W2069851017 @default.
- W4236098321 hasRelatedWork W2280569998 @default.
- W4236098321 hasRelatedWork W2395415088 @default.
- W4236098321 hasRelatedWork W2414570195 @default.
- W4236098321 hasRelatedWork W2979641679 @default.
- W4236098321 hasRelatedWork W2997627044 @default.
- W4236098321 hasRelatedWork W3015148478 @default.
- W4236098321 hasVolume "2" @default.
- W4236098321 isParatext "false" @default.
- W4236098321 isRetracted "false" @default.
- W4236098321 workType "article" @default.